Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 78251-78300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05736549
Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2
PHASE2Recruiting
66 participants
Started: Feb 7, 2023 · Completed: Mar 31, 2028
2 conditions2 sponsors2 locations
NCT05616026
Texts for Diabetes Control Among Homeless Persons
NARecruiting
100 participants
Started: Feb 7, 2023 · Completed: Nov 15, 2025
1 condition2 sponsors2 locations
NCT05426005
Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer
PHASE1/PHASE2Recruiting
28 participants
Started: Feb 7, 2023 · Completed: Jul 1, 2027
3 conditions1 sponsor1 location
NCT05630105
Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene
N/ARecruiting
430 participants
Started: Feb 7, 2023 · Completed: Jan 31, 2048
1 condition1 sponsor1 location
NCT05739188
Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM
PHASE1/PHASE2Recruiting
18 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT05672225
Two-channel IV-PCA With Dexmedetomidine
NARecruiting
110 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06320106
Assessment of Navigation Abilities in Children With Cerebral Palsy and Their Peers
NARecruiting
26 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05628870
A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer
PHASE1Recruiting
102 participants
Started: Feb 7, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06362174
Capsule & Omics for pRedicting Exacerbation of Crohn's Disease
N/AActive, not recruiting
62 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05705570
Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies
PHASE1Recruiting
30 participants
Started: Feb 7, 2023 · Completed: Dec 1, 2028
6 conditions2 sponsors1 location
NCT05710952
Impact of Orthodontic Treatment on the Temporomandibular Joints (TMJ) Assessed by Modjaw
NARecruiting
32 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05673824
Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.
PHASE4Recruiting
53 participants
Started: Feb 7, 2023 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT05538663
Intravesical BCG vs GEMDOCE in NMIBC
PHASE3Recruiting
870 participants
Started: Feb 7, 2023 · Completed: Oct 31, 2030
1 condition2 sponsors229 locations
NCT05718700
Study of Bulevirtide in Participants With Chronic Hepatitis D Infection
N/ARecruiting
170 participants
Started: Feb 7, 2023 · Completed: Nov 30, 2027
1 condition1 sponsor53 locations
NCT05635877
Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients
PHASE4Recruiting
2,000 participants
Started: Feb 7, 2023 · Completed: Dec 30, 2026
3 conditions1 sponsor1 location
NCT06087705
Real-life Assessment of the Safety and Performance of the SYNOVIUM HCS Device
N/ARecruiting
134 participants
Started: Feb 7, 2023 · Completed: Aug 1, 2024
1 condition2 sponsors1 location
NCT06626750
Evaluating Stress Management Strategies Within the School Readiness Parenting Program
NAActive, not recruiting
120 participants
Started: Feb 7, 2023 · Completed: May 29, 2026
5 conditions1 sponsor1 location
NCT05648864
Viamigo for People With Dementia and Their Informal Caregivers
NARecruiting
48 participants
Started: Feb 7, 2023 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05259709
A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab
PHASE1Recruiting
50 participants
Started: Feb 7, 2023 · Completed: Jan 6, 2027
2 conditions1 sponsor1 location
NCT06736470
Surgical Suction Aspirates Fluorescence Measurement
N/ARecruiting
25 participants
Started: Feb 7, 2023 · Completed: Jan 1, 2026
2 conditions2 sponsors1 location
NCT05496998
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
NARecruiting
400 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2038
1 condition1 sponsor36 locations
NCT05667506
A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
PHASE1/PHASE2Recruiting
47 participants
Started: Feb 7, 2023 · Completed: May 30, 2027
1 condition1 sponsor9 locations
NCT05742360
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
N/ARecruiting
227 participants
Started: Feb 7, 2023 · Completed: Mar 1, 2028
1 condition2 sponsors2 locations
NCT06048445
Placement of Biliary Drainage Stent to Prevent Biliary Intestinal Anastomosis After Liver Transplantation in Children
N/ARecruiting
108 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05757687
Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH
NARecruiting
11 participants
Started: Feb 7, 2023 · Completed: Sep 1, 2026
2 conditions1 sponsor5 locations
NCT05927623
Multifaceted Intervention Using Telehealth to Reduce the Risk of Falls and Fractures in Older Men
NAActive, not recruiting
60 participants
Started: Feb 7, 2023 · Completed: Mar 31, 2026
6 conditions2 sponsors5 locations
NCT05520723
Preventive stRategy for IMMU132-relatED AEs in TNBC - PRIMED
PHASE2Active, not recruiting
50 participants
Started: Feb 7, 2023 · Completed: Dec 14, 2025
2 conditions2 sponsors10 locations
NCT05548556
A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy
PHASE2Active, not recruiting
48 participants
Started: Feb 7, 2023 · Completed: Nov 2, 2026
1 condition1 sponsor10 locations
NCT05733013
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
N/ARecruiting
100 participants
Started: Feb 7, 2023 · Completed: Feb 7, 2028
3 conditions1 sponsor1 location
NCT06324708
Analysis of Defined Elements on DXA in Patients Undergoing Hip Arthroplasty
NARecruiting
69 participants
Started: Feb 7, 2023 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05630989
A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy
N/ARecruiting
80 participants
Started: Feb 7, 2023 · Completed: Aug 1, 2027
1 condition1 sponsor1 location
NCT05447559
Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study
PHASE4Recruiting
9,180 participants
Started: Feb 7, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors22 locations
NCT05570929
LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration
N/ARecruiting
20 participants
Started: Feb 7, 2023 · Completed: Nov 1, 2026
1 condition1 sponsor1 location
NCT05339217
Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus
PHASE3Recruiting
60 participants
Started: Feb 7, 2023 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT05574491
Effectiveness of Traditional and Computerized Versions of Super Skills for Life in Children
NAActive, not recruiting
105 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2024
6 conditions1 sponsor1 location
NCT05797896
Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study
N/AActive, not recruiting
250 participants
Started: Feb 7, 2023 · Completed: Jul 31, 2027
7 conditions1 sponsor22 locations
NCT05605535
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
PHASE2Active, not recruiting
88 participants
Started: Feb 7, 2023 · Completed: Sep 15, 2027
5 conditions2 sponsors14 locations
NCT05629429
Olaparib Maintenance Therapy in Metastatic Breast Cancer
PHASE2Recruiting
300 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors3 locations
NCT05805241
Pharmacogenetics Analysis of Fentanyl Administered in Newborns
N/ARecruiting
66 participants
Started: Feb 7, 2023 · Completed: Mar 15, 2026
3 conditions1 sponsor1 location
NCT05726734
Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial
PHASE4Not yet recruiting
100 participants
Started: Feb 6, 2023 · Completed: Feb 6, 2026
1 condition1 sponsor1 location
NCT05672121
Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
PHASE1/PHASE2Recruiting
42 participants
Started: Feb 6, 2023 · Completed: Dec 28, 2026
1 condition1 sponsor1 location
NCT05830643
Enhancing Consensual Social Skills to Prevent Non-consensual Sexual Acts
NAEnrolling by invitation
60 participants
Started: Feb 6, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05812677
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer
EARLY_PHASE1Recruiting
20 participants
Started: Feb 6, 2023 · Completed: Feb 6, 2026
3 conditions2 sponsors1 location
NCT05767723
Platelet Sub-study of the Neomindset Trial
PHASE4Active, not recruiting
48 participants
Started: Feb 6, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05520762
Hospital Airway Resuscitation Trial
NARecruiting
1,060 participants
Started: Feb 6, 2023 · Completed: Feb 28, 2027
2 conditions2 sponsors1 location
NCT06168968
Multidisciplinary Approach to Reduce Cardiovascular Health Disparities
N/ARecruiting
400 participants
Started: Feb 6, 2023 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT06004544
Prospective Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant Women
N/ARecruiting
10,000 participants
Started: Feb 6, 2023 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT05731024
Closed-loop Synchronization Versus Conventional Synchronization
NARecruiting
15 participants
Started: Feb 6, 2023 · Completed: Dec 30, 2025
2 conditions2 sponsors5 locations
NCT05737030
Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome
PHASE4Active, not recruiting
55 participants
Started: Feb 6, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05579275
Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors
EARLY_PHASE1Recruiting
24 participants
Started: Feb 6, 2023 · Completed: Apr 28, 2027
1 condition1 sponsor1 location